NN-1213

N/A

Report date: 2022/02/18 10:30:41
NME

Base Information

Drug NameNN-1213
Drug Alias NameNN-1213
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAmylin receptor agonists
TargetsAmylin Receptor
Therapy Area/IndicationsAlcoholismObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNovo Nordisk A/S
China Registration ClassN/A

Develop Information

Active CompaniesNovo Nordisk A/S
Inactive CompaniesN/A
Active IndicationsAlcoholismObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A